{
      "Rank": 66,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "HB-adMSCs will be infused three times over a six week period, spaced 14 days apart"
      ],
      "ArmGroupInterventionName": [
            "Biological: HB-adMSCs"
      ],
      "ArmGroupLabel": [
            "HB-adMSC"
      ],
      "ArmGroupType": [
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT04063215"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This study aims to determine the safety of HB-adMSC infusion and treatment effects of HB-adMSC infusion on brain structure, neurocognitive/functional outcomes, and neuroinflammation after subacute and chronic neurological injury in adults."
      ],
      "BriefTitle": [
            "A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [
            "OTHER"
      ],
      "CollaboratorName": [
            "The University of Texas Health Science Center, Houston"
      ],
      "CompletionDate": [
            "December 31, 2024"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Traumatic Brain Injury"
      ],
      "ConditionAncestorId": [
            "D000002493",
            "D000009422",
            "D000006259",
            "D000020196",
            "D000000860",
            "D000012818",
            "D000002561",
            "D000014652",
            "D000002318",
            "D000002534"
      ],
      "ConditionAncestorTerm": [
            "Central Nervous System Diseases",
            "Nervous System Diseases",
            "Craniocerebral Trauma",
            "Trauma, Nervous System",
            "Hypoxia",
            "Signs and Symptoms, Respiratory",
            "Cerebrovascular Disorders",
            "Vascular Diseases",
            "Cardiovascular Diseases",
            "Hypoxia, Brain"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC10",
            "BC26",
            "All",
            "BC14",
            "BC23",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Nervous System Diseases",
            "Wounds and Injuries",
            "All Conditions",
            "Heart and Blood Diseases",
            "Symptoms and General Pathology",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Brain Injury",
            "Traumatic Brain Injury",
            "Ischemic Encephalopathy",
            "Encephalopathy",
            "Hypoxic Ischemic Encephalopathy",
            "Injury"
      ],
      "ConditionBrowseLeafId": [
            "M4359",
            "M628",
            "M21459",
            "M12309",
            "M4948",
            "M9695",
            "M4946",
            "M8708",
            "M21266",
            "M3337",
            "M21176",
            "M4356",
            "M21813",
            "M16837",
            "M4894",
            "M8501",
            "M14775",
            "M4962",
            "M16552",
            "M4935",
            "T1303"
      ],
      "ConditionBrowseLeafName": [
            "Brain Injuries",
            "Brain Injuries, Traumatic",
            "Stroke",
            "Paralysis",
            "Cerebral Palsy",
            "Ischemia",
            "Brain Ischemia",
            "Hemorrhage",
            "Intracranial Hemorrhages",
            "Hypoxia",
            "Trauma, Nervous System",
            "Brain Diseases",
            "Hypoxia-Ischemia, Brain",
            "Wounds and Injuries",
            "Central Nervous System Diseases",
            "Craniocerebral Trauma",
            "Signs and Symptoms, Respiratory",
            "Cerebrovascular Disorders",
            "Vascular Diseases",
            "Hypoxia, Brain",
            "Chronic Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000001930",
            "D000070642",
            "D000001927",
            "D000002545",
            "D000020925",
            "D000014947"
      ],
      "ConditionMeshTerm": [
            "Brain Injuries",
            "Brain Injuries, Traumatic",
            "Brain Diseases",
            "Brain Ischemia",
            "Hypoxia-Ischemia, Brain",
            "Wounds and Injuries"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "N/A"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [
            "Single arm, non-randomized study to determine safety and treatment effect of three infusions of HB-adMSC (2 x 10^8 total cells per dose) in adult patients with sub-acute or chronic neurological injury"
      ],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "This study aims to determine the safety of HB-adMSC infusion and treatment effects of HB-adMSC infusion on global gray and/or white matter, as well as structural integrity of GM and WM regions of interest in the corpus callous and corticospinal tracts as measured by fractional anisotropy (FA) and mean diffusivity (MD) in specific regions known to correlate with specific neurocognitive deficits in patients after neurological injury."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nadults between 18 and 55 years of age\ndocumented head injury with functional neurological damage to the central nervous system unlikely to improve with present standard of care approaches\na Glasgow Outcome Scale-Extended (GOS-E) score > 2 and \u2264 6\nonset or diagnosis of the injury or disease process greater than 6 months\nability to obtain consent from the subject of their legally authorized representative (LAR)\nability to speak English or Spanish *required for validated neurocognitive outcome testing) -\n\nExclusion Criteria:\n\nknown history of:\n\na) intellectual deficiency or psychiatric conditions likely to invalidate our ability to assess changes in cognition or behavior, b) recently treated infection, c) renal disease or altered renal function (screening serum creatinine > 1.5 mg/dL), d) hepatic disease or altered liver function (screening SGPT > 150 U/L or T. Bilirubin >1.3 mg/dL), e) cancer, f) immunosuppression (screening WBC < 3, 000 cells/ml), g) HIV+, h) chemical or ETOH dependency that in the opinion of the investigator would preclude participation in the study, i) acute or chronic lung disease requiring significant medication, oxygen supplementation, or mechanical ventilation, j) bleeding disorders including immune-mediated heparin-induced thrombocytopenia, k) known sensitivity to heparin, Lovenox, and pork products, l) individuals with mechanical prosthetic heart valves.\n\nNormal brain CT/MRI exam\nSpinal deformity, spinal surgery (including repeated epidural or spinal punctures), or spinal cord injury diagnosed by CT/MR or clinical exam\ndiagnosed with a genetic or metabolic disorder related to the neurologic condition\nother acute or chronic medical conditions that, in the opinion of the investigator, may increase the risks associated with study participation\nfor women of child bearing potential, a positive pregnancy test at the screening visit, or, for both women and men, unwillingness to comply with acceptable methods of birth control during the study\nparticipation in a concurrent interventional study\ninability to undergo the diagnostic tests (PET/DT-MRI) or unwilling/unable to cooperate with the diagnostic tests and outcome assessments\nunwilling or unable to return for follow-up study visits -"
      ],
      "EnrollmentCount": [
            "24"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "HB-adMSC"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Hope Biosciences autologous adipose-derived mesenchymal stem cells"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "HB-adMSCs"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "Yes"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "severe",
            "hypoxic-ischemic encephalopathy",
            "stroke",
            "intracranial hemorrhage",
            "cerebral palsy",
            "chronic",
            "neurological injury"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "May 31, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "May 27, 2022"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Hope Biosciences"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Houston"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "United States"
      ],
      "LocationFacility": [
            "Memorial Hermann Hospital-Clinical Research Unit (MMH-CRU)"
      ],
      "LocationState": [
            "Texas"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "77030"
      ],
      "MaximumAge": [
            "55 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Hope Biosciences"
      ],
      "OrgStudyId": [
            "HBTBI01"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "The University of Texas Health Science Center, Houston"
      ],
      "OverallOfficialName": [
            "Charles S Cox, MD"
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Active, not recruiting"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "May 27, 2022"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [
            "clinical lab evaluation of level of glucose in the blood (mg/dL)",
            "clinical lab evaluation of level of calcium in the blood (mg/dL)",
            "clinical lab evaluation of level of albumin in the blood (g/dL)",
            "clinical lab evaluation of total protein in the blood (g/dL)",
            "clinical lab evaluation of total sodium in the blood (mmol/L)",
            "clinical lab evaluation of total carbon dioxide in the blood (mmol/L)",
            "clinical lab evaluation of potassium in the blood (mmol/L)",
            "clinical lab evaluation of chloride in the blood (mmol/L)",
            "clinical evaluation of blood urea nitrogen (BUN) (mg/dL)",
            "clinical evaluation of creatinine in blood (mg/dL)",
            "clinical evaluation of alkaline phosphatase (ALP) in blood (IU/L)",
            "clinical evaluation of alanine aminotransferase (ALT) in blood (IU/L)",
            "clinical evaluation of aspartate aminotransferase (AST) in blood (IU/L)",
            "clinical evaluation of total bilirubin in blood (mg/dL)",
            "clinical evaluation of white blood cells (WBC) in blood (x 10^3/uL)",
            "clinical evaluation of red blood cells (RBC) in blood (x 10^6/uL)",
            "clinical evaluation of hemoglobin in blood (g/dL)",
            "clinical evaluation of hematocrit in blood (%)",
            "clinical evaluation of mean corpuscular volume (MCV) in blood (fL)",
            "clinical evaluation of mean corpuscular hemoglobin (MCH) in blood (pg)",
            "clinical evaluation of mean corpuscular hemoglobin concentration (MCHC) in blood (g/dL)",
            "clinical evaluation of red cell distribution width (RDW) in blood (%)",
            "clinical evaluation of neutrophils in blood (%)",
            "clinical evaluation of lymphocytes in blood (%)",
            "clinical evaluation of monocytes in blood (%)",
            "clinical evaluation of eosinophils in blood (%)",
            "clinical evaluation of basophils in blood (%)",
            "clinical evaluation of absolute neutrophils in blood (x 10^3/uL)",
            "clinical evaluation of absolute lymphocytes in blood (x 10^3/uL)",
            "clinical evaluation of absolute monocytes in blood (x 10^3/uL)",
            "clinical evaluation of absolute eosinophils in blood (x 10^3/uL)",
            "clinical evaluation of absolute basophils in blood (x 10^3/uL)",
            "clinical evaluation of immature granulocytes in blood (%)",
            "clinical evaluation of absolute immature granulocytes in blood (x 10^3/uL)",
            "clinical evaluation of platelets in blood (x 10^3/uL)",
            "clinical evaluation of time for blood to coagulate (seconds)",
            "clinical evaluation of international normalized ratio of blood coagulation (no unit)",
            "clinical evaluation of human chorionic gonadotropin (hCG) in urine (positive/negative)"
      ],
      "PrimaryOutcomeMeasure": [
            "Glucose",
            "Calcium",
            "Albumin",
            "Total Protein",
            "Sodium",
            "Total carbon dioxide",
            "Potassium",
            "Chloride",
            "BUN",
            "Creatinine",
            "Alkaline phosphatase",
            "Alanine aminotransferase",
            "Aspartate aminotransferase",
            "Total Bilirubin",
            "White blood cell",
            "Red blood cell",
            "Hemoglobin",
            "Hematocrit",
            "Mean corpuscular volume",
            "Mean corpuscular hemoglobin",
            "Mean corpuscular hemoglobin concentration",
            "Red cell distribution width",
            "Neutrophils",
            "Lymphs",
            "Monocytes",
            "Eos",
            "Basos",
            "Absolute Neutrophils",
            "Absolute Lymphs",
            "Absolute monocytes",
            "Absolute Eos",
            "Absolute Basos",
            "Immature Granulocytes",
            "Absolute Immature Granulocytes",
            "Platelets",
            "Prothrombin Time",
            "INR",
            "Urine Pregnancy"
      ],
      "PrimaryOutcomeTimeFrame": [
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)",
            "Screening (visit 1),change from screening at visit 3, change from screening at visit 4, change from screening at visit 5, change from screening at 6 months post-infusion (visit 6), change from screening at 1 year post-infusion (visit 7)"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "DTI to assess macro- and micro-structural properties",
            "[11C]ER-176 tracer/label to identify brain proteins associated with neuroinflammatory response regulation",
            "Dichotomized-Glasgow Outcomes Score (GOSE) to evaluate affect, functional outcome, and neuropsychological function",
            "Galveston Orientation and Amnesia Test (GOAT) evaluation of cognition",
            "Rivermead Post-Concussion Symptoms Questionnaire (RPSQ) evaluation to identify presence and severity of concussive symptoms",
            "Automated Neuropsychological Assessment Metrics (ANAM) evaluation of attention, concentration, reaction time, memory, processing speed, and decision-making",
            "Verbal Selective Reminding Test (VSRT) to evaluate verbal learning and memory",
            "Verbal Fluency Test (VFT) to evaluate vocabulary size, lexical access speed, updating, and inhibition ability",
            "Stroop to evaluate selective attention and cognitive flexibility",
            "measure IL-1\u03b1 via a bead-based, flow cytometric ELISA for the cytokines",
            "measure IL-4 via a bead-based, flow cytometric ELISA for the cytokines",
            "measure TNF\u03b1 via a bead-based, flow cytometric ELISA for the cytokines",
            "measure IL-6 via a bead-based, flow cytometric ELISA for the cytokines",
            "measure IL-10 via a bead-based, flow cytometric ELISA for the cytokines",
            "measure concentration of albumin via BCG immunochemical analysis"
      ],
      "SecondaryOutcomeMeasure": [
            "Whole brain MRI",
            "PET/DT-MRI",
            "Glasgow Outcome Score",
            "Galveston Orientation and Amnesia Test",
            "Rivermead Post-Concussion Symptoms Questionnaire",
            "Automated Neuropsychological Assessment Metrics",
            "Verbal Selective Reminding Test",
            "Verbal Fluency Test",
            "Stroop",
            "Interleukin 1-alpha",
            "Interleukin 4",
            "Tumor necrosis factor alpha",
            "Interleukin 6",
            "Interleukin 10",
            "Albumin"
      ],
      "SecondaryOutcomeTimeFrame": [
            "Baseline, change from baseline at 6 months post-infusion",
            "Baseline, change from baseline at 6 months post-infusion",
            "Baseline, change from baseline at Imaging visit #2, change from baseline at 6 months post-infusion, change from baseline at 1 year post-infusion",
            "Baseline, change from baseline at Imaging visit #2, change from baseline at 6 months post-infusion, change from baseline at 1 year post-infusion",
            "Baseline, change from baseline at Imaging visit #2, change from baseline at 6 months post-infusion, change from baseline at 1 year post-infusion",
            "Baseline, change from baseline at Imaging visit #2, change from baseline at 6 months post-infusion, change from baseline at 1 year post-infusion",
            "Baseline, change from baseline at Imaging visit #2, change from baseline at 6 months post-infusion, change from baseline at 1 year post-infusion",
            "Baseline, change from baseline at Imaging visit #2, change from baseline at 6 months post-infusion, change from baseline at 1 year post-infusion",
            "Baseline, change from baseline at Imaging visit #2, change from baseline at 6 months post-infusion, change from baseline at 1 year post-infusion",
            "Baseline, change from baseline at 6 months post-infusion, change from baseline 1 year post-infusion",
            "Baseline, change from baseline at 6 months post-infusion, change from baseline 1 year post-infusion",
            "Baseline, change from baseline at 6 months post-infusion, change from baseline 1 year post-infusion",
            "Baseline, change from baseline at 6 months post-infusion, change from baseline 1 year post-infusion",
            "Baseline, change from baseline at 6 months post-infusion, change from baseline 1 year post-infusion",
            "Baseline, change from baseline at 6 months post-infusion, change from baseline 1 year post-infusion"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 1, 2020"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "April 2022"
      ],
      "StdAge": [
            "Adult"
      ],
      "StudyFirstPostDate": [
            "August 21, 2019"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "August 13, 2019"
      ],
      "StudyFirstSubmitQCDate": [
            "August 17, 2019"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}